Cleveland Bakers and Teamsters Health and Welfare Fund et al v. Purdue Pharma L.P. et al
Case Number:
1:18-op-45432
Court:
Nature of Suit:
Racketeer/Corrupt Organization
Judge:
Firms
- Alston & Bird
- Barnes & Thornburg
- Bartlit Beck
- Covington & Burling
- Faulkner Hoffman
- Jones Day
- Morgan Lewis
- Robbins Geller
- Spangenberg Shibley
- Williams & Connolly
- Zuckerman Spaeder
Companies
- Allergan PLC
- Anda Inc.
- Cardinal Health Inc.
- Cephalon Inc.
- CVS Health Corp.
- Discount Drug Mart Inc.
- Endo International PLC
- H.D. Smith LLC
- Johnson & Johnson
- Mallinckrodt PLC
- McKesson Corp.
- Noramco Inc.
- Par Pharmaceutical Cos. Inc.
- Purdue Pharma LP
- Rite Aid Corp.
- Teva Pharmaceutical Industries Ltd.
- Walgreens Boots Alliance Inc.
- Walmart Inc.
- Warner Chilcott Limited
Sectors & Industries:
-
August 30, 2024
McKesson, Others To Pay Benefit Plans $300M In Opioid Deal
McKesson Corp., Cardinal Health Inc. and Cencora Inc. have agreed to pay a group of benefit plans a combined $300 million to resolve allegations that the drug distributors fanned the flames of the opioid epidemic, according to a filing Friday in Ohio federal court.
-
June 07, 2024
Motley Rice Allocated Biggest Share Of $2B Opioid Fees
A panel directed with allocating $2.13 billion in attorney fees stemming from opioid settlements has recommended awarding the largest shares of the pot to Motley Rice LLC, Simmons Hanly Conroy LLC and Napoli Shkolnik PLLC, according to a report filed Friday in Ohio federal court.
-
March 08, 2023
Opioid Judge Eyes New Bellwethers Amid 'Unwieldy' Delays
The Ohio federal judge guiding multidistrict opioid litigation is opening new bellwether frontiers involving pharmacy chains and health insurance entities that have sat on the MDL's sidelines, and he signaled impatience this week with "an inefficient use of judicial resources" amid lengthy settlement talks.
-
February 21, 2020
Opioid Cos. Must Face Benefit Plans' Suit In MDL
The Ohio federal judge overseeing the opioid multidistrict litigation allowed union benefit plans to go forward with their suit alleging that opioid companies created a public nuisance, finding that they claim injuries different from the harm to health and safety suffered by the general public.